Related Experiment Videos
Prognostic parameters in low-grade non-Hodgkin's lymphomas
T Zemunik1, J Vucković, G Forenpoher
1Department of Biology, Zagreb University School of Medicine Split Branch, Croatia.
Neoplasma
|January 1, 1997
Summary
In patients with low-grade non-Hodgkin's lymphomas (LG NHL), lymphocytic types and low-proliferative lymphomas showed better survival. B-symptoms, serum LDH, and complete remission were significant prognostic factors.
Area of Science:
- Oncology
- Hematology
- Clinical Research
Background:
- Low-grade non-Hodgkin's lymphomas (LG NHL) represent a heterogeneous group of lymphoid malignancies.
- Accurate prognostic factors are crucial for guiding treatment strategies and predicting patient outcomes in LG NHL.
Purpose of the Study:
- To identify significant independent prognostic factors for survival in patients with LG NHL.
- To evaluate the impact of various clinical and pathological variables on patient outcomes.
Main Methods:
- Multivariate analysis was performed on data from 73 patients with LG NHL.
- Variables analyzed included pathological type, clinical stage, B-symptoms, laboratory markers (ESR, hemoglobin, WBC, lymphocyte count, gamma globulin, LDH), mitotic rate, and remission status.
Main Results:
- Lymphocytic lymphoma subtypes demonstrated superior survival rates within the LG NHL cohort.
- Low-proliferative lymphomas exhibited better survival compared to high-proliferative lymphomas at both 3 and 10 years.
- Significant independent prognostic factors identified were B-symptoms, serum total lactic dehydrogenase (LDH) level, and achievement of complete remission.
Conclusions:
- Pathological subtype and proliferative rate are important determinants of survival in LG NHL.
- Clinical indicators such as B-symptoms, LDH levels, and remission status are critical for prognostication in LG NHL.